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abstract: Prokineticin-1 (PROK1) is a multifunctional secreted protein which signals via the G-protein coupled receptor, PROKR1.
Previous data from our laboratory using a human genome survey microarray showed that PROK1–prokineticin receptor 1 (PROKR1) signal-
ling regulates numerous genes important for establishment of early pregnancy, including the cytokine interleukin (IL)-11. Here, we have
shown that PROK1–PROKR1 induces the expression of IL-11 in PROKR1 Ishikawa cells and ﬁrst trimester decidua via the calcium–calci-
neurin signalling pathway in a guanine nucleotide-binding protein (Gq/11), extracellular signal-regulated kinases, Ca
2þ and calcineurin–nuclear
factor of activated T cells dependent manner. Conversely, treatment of human decidua with a lentiviral miRNA to abolish endogenous
PROK1 expression results in a signiﬁcant reduction in IL-11 expression and secretion. Importantly, we have also shown a regulatory role
for the regulator of calcineurin 1 isoform 4 (RCAN1-4). Overexpression of RCAN1-4 in PROKR1 Ishikawa cells using an adenovirus
leads to a reduction in PROK1 induced IL-11 indicating that RCAN1-4 is a negative regulator in the calcineurin-mediated signalling to IL-
11. Finally, we have shown the potential for both autocrine and paracrine signalling in the human endometrium by co-localizing IL-11, IL-
11Ra and PROKR1 within the stromal and glandular epithelial cells of non-pregnant endometrium and ﬁrst trimester decidua. Overall we
have identiﬁed and characterized the signalling components of a novel PROK1–PROKR1 signalling pathway regulating IL-11.
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Introduction
The prokineticins (PROK) are a family of multifunctional secreted pro-
teins consisting of two members called prokineticin 1 (PROK1), also
known as endocrine gland vascular endothelial growth factor,
EG-VEGF (LeCouter et al., 2001; Li et al., 2001) and PROK2, also
known as Bombina variegata 8, Bv8 (Mollay et al., 1999). Prokineticins
have been shown to regulate angiogenesis (Urayama et al., 2007),
haematopoiesis (LeCouter et al., 2004), intestinal contraction
(Li et al., 2001), neurogenesis (Ng et al., 2005) and pain sensation
(Negri et al., 2006). Prokineticins bind to two closely related
G-protein coupled receptors, known as prokineticin receptor
1 (PROKR1) and prokineticin receptor 2 (PROKR2), with both
receptors able to bind PROK1 and PROK2 with similar afﬁnities
(Soga et al., 2002). Prokineticins and their receptors are expressed
in the male and female reproductive tracts (reviewed in Maldonado-
Perez et al., 2007). PROK1 and PROKR1 show differential expression
across the menstrual cycle and in ﬁrst trimester decidua, with
increased endometrial expression of PROK1 observed in the mid-
secretory phase and both PROK1 and PROKR1 increased in ﬁrst tri-
mester decidua. PROK1 and PROKR1 immunolocalize to stromal,
endothelial and glandular epithelial cells of the endometrium and
smooth muscle and endothelial cells in the myometrium (Battersby
et al., 2004; Evans et al., 2008). Recent data from our laboratory
demonstrated that PROK1–PROKR1 signalling regulates genes impor-
tant for the establishment of early pregnancy. These genes included
& The Author 2009. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which
permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Molecular Human Reproduction, Vol.16, No.3 pp. 158–169, 2010
Advanced Access publication on October 3, 2009 doi:10.1093/molehr/gap084leukemia inhibitory factor (LIF), cyclooxygenase (COX)-2,
interleukin-8 and interleukin-11 (IL-11) (Evans et al., 2008, 2009).
In the present study, we investigated the role of PROK1–PROKR1
modulation of IL-11. IL-11 is a member of the GP130 family of cytokines
which includes LIF, interleukin-6 and cardiotrophin 1 (Dimitriadis et al.,
2005a, b). IL-11 signals initially by binding to its low afﬁnity receptor
IL-11Ra which subsequently recruits and binds the GP130 subunit,
dimerizes and forms an active high afﬁnity complex (Bilinski et al., 1998).
Signalling from IL-11Ra-GP130 is often via the mitogen-activated protein
kinase signalling pathways (Yin and Yang, 1994; Yang and Yin, 1995).
IL-11 is essential for mouse implantation. Female mice with a null
mutation in IL-11Ra are infertile due to poor decidualization resulting
in over invasiveness of the implanting blastocyst (Bilinski et al., 1998;
Robb et al., 1998). Further studies using the IL-11Ra mice have eluci-
dated a role for IL-11 in the differentiation of uterine natural killer
(uNK) cells at the maternal–fetal interface (Ain et al., 2004). In human
endometrial stromal cells, IL-11 has been shown to advance
progesterone-induced decidualization implying a role for IL-11 in
preparing the endometrium for implantation (Dimitriadis et al., 2002).
Furthermore relaxin and prostaglandin E2 (PGE2) have both been
shown to increase IL-11 mRNA and protein secretion in decidualized
endometrialstromalcells(Dimitriadisetal.,2005a,b).Finally,Karpovich
et al. (2005) have shown that decidualized human endometrial stromal
cells taken from patients with primary infertility produce lower levels
of IL-11 compared with cells derived from fertile women indicating a
potential role for IL-11 in decidualization and successful pregnancy.
In this study, we have conﬁrmed our initial human genome survey
microarray observation that PROK1 regulates IL-11 expression
(Evans et al., 2008). Importantly in the present study, we have
mapped out the cellular and molecular pathways regulating IL-11 via
PROK1 in endometrium and ﬁrst trimester decidua. We found that
PROK1–PROKR1 regulates IL-11 via the calcineurin signalling
pathway in a guanine nucleotide-binding protein (Gq/11), calcium and
extracellular signal-regulated kinase (ERK) dependent manner in
human endometrium and ﬁrst trimester decidua. We conﬁrmed the
role of PROK1 in regulating basal IL-11 expression in ﬁrst trimester
decidua by using a miRNA targeted to PROK1. Furthermore we
have shown that overexpression of regulator of calcineurin 1
isoform 4 (RCAN1-4)—a negative regulator of calcineurin signal-
ling—leads to a reduction in PROK1 induced IL-11, indicating that
RCAN1-4 is acting as a negative regulator in the signalling pathway
mediating IL-11 expression. IL-11 is known to be essential for success-
ful decidualization and implantation and our data have characterised a
novel pathway that regulates IL-11 secretion via PROK1-PROKR1 in
human endometrium and ﬁrst trimester decidua.
Experimental procedures
Reagents
DMEM F-12 GLUTAMAX cell culture medium was purchased from
Invitrogen Life Technologies (Paisley, UK). YM-254890 was kindly
donated by Astellas Pharma Inc (Tsukuba, Japan). Cyclosporin A (Cal-
cineurin inhibitor), Inhibitor of NFAT-Calcineurin Association-6
(INCA-6), PD98059 (MAPK kinase (MEK) inhibitor) and
BAPTA-AM (Ca
2þ chelator) were purchased from Calbiochem (Not-
tingham, UK). EGTA (Ca
2þ chelator) was purchased from Sigma
(Dorset, UK). PROK1 was purchased from Peprotech (London, UK)
and used at 40 nM in all experiments.
Patients and tissue collection
Non-pregnant endometrial tissue (n ¼ 44) at different stages of the
menstrual cycle was collected from women undergoing surgery for
minor gynaecological procedures using an endometrial suction
curette (Pipelle, Laboratoire CCD, France). Women had no under-
lying endometrial pathology and had regular menstrual cycles of
between 25 and 35 days. None of these women had received a hor-
monal preparation in the 3 months preceding biopsy collection. Biop-
sies were dated according to stated last menstrual period and
conﬁrmed by histological assessment according to criteria of Noyes
et al. (1975). First trimester decidua (7–12 weeks, n ¼ 25) was col-
lected from women undergoing elective ﬁrst-trimester surgical termin-
ation of pregnancy. Ethical approval was obtained from Lothian
Research Ethics Committee and written informed consent was
obtained from all subjects before tissue collection.
Cell and tissue culture and treatment
Ishikawa endometrial adenocarcinoma cells were obtained from the
European Collection of Cell Culture (Wiltshire, UK). Stable
PROKR1 transfected cells were designed and characterized as
described before (Evans et al., 2008). These PROKR1 Ishikawa cells
were cultured in DMEM/F-12 cultured medium supplemented with
10% fetal bovine serum and a maintenance dose of 200 mg/ml of
G418 antibiotic.
Tissue explants were ﬁnely chopped with scissors and maintained in
DMEM. Tissue was divided into equal portions for experimental
procedures.
Cells and tissue were incubated in serum free DMEM overnight
prior to treatments of PROK1 alone or in the presence of inhibitors
(concentrations in ﬁgure legends) for times indicated in ﬁgure
legends. Inhibitors were added 1 h prior to PROK1. Cells and
tissues were harvested with conditioned media collected for enzyme
linked immunosorbent assays (ELISAs) and RNA extracted for RT–
PCR analysis.
Tissue was infected with lentivirus expressing PROK1 miRNA con-
structs for 72 h as described by Evans et al. (2009). Oligonucleotides
encoding human PROK1 miRNA constructs were obtained from Invi-
trogen and inserted into the pcDNA6.2-GW/EmGFP-miR vector and
used for transient transfections. These were recombined to create
plenti6/V5-EmGFP-miR negative control and pLenti6/V5-EmGFP-
hum-PROK1-72, -287 and -72_287 chained (Evans et al., 2009). Fol-
lowing infection tissue and medium were harvested, and RNA or
protein was extracted for RT–PCR or ELISA analysis.
Taqman quantitative RT–PCR
Total RNA was extracted from cells using Total RNA Isolation
Reagent (TRI reagent) from Sigma (Poole, UK) following manufactures
instructions using phase lock tubes from Eppendorf (Cambridge, UK).
Quantiﬁed RNA samples were reverse transcribed and quantitative
RT–PCR was performed as described before (Sales et al., 2004)
using the following primers and probes: IL-11: forward:
50-CCCAGTTACCCAAGCATCCA-30: reverse: 50-AGACAGAGAA
CAGGGAATTAAATGTGT-30 and probe 50-FAM-CCCCAGCTC
PROK1 modulates IL-11 expression via PROKR1 159TCAGACAAATCGCCC-30; IL-11Ra: forward: 50-CCAGCCAGAT
CAGCGGTTTA-30: reverse: 50-TGGCTATCAGCTCCTAGGACTG
T-30 and probe 50-FAM-CCACCCGCTACCTCACCTCCTACAGG-
30; GP130 forward: 50-CTGAATGGGCAACACACAAGTT-30:
reverse: 50-CCAGACTTCAATGTTGACAAAATACA-30 and probe
50-FAM-CAAAGCAAAACGTGACACCCCCACC-30. The expression
of analysed genes was normalized for RNA loading using 18S riboso-
mal RNA. All results are expressed as relative to a positive RNA stan-
dard (cDNA obtained from a single endometrial tissue) included in all
reactions.
Enzyme linked immunosorbent assay
Secreted IL-11 was quantiﬁed using an in-house ELISA. The assay was
based on the two step direct sandwich ELISA, using a monoclonal anti-
body against human IL-11 as the capture antibody and a biotinylated
antibody against human IL-11 as the detection antibody (both from
R&D Systems, Oxford, UK). Brieﬂy, plates were coated overnight at
48C with capture antibody added at 100 ml/well followed by
100 ml/well of coating solution for 1 h at room temperature. The
coating solution was removed and the plates stored at 2208C.
Before use, the plates were washed twice in wash buffer (0.05%
Tween-20, 10 mM TRIS, 0.15 M NaCl). Recombinant IL-11 standard
(R&D, Oxford, UK) was diluted in ELISA buffer (4000–31.25 pg/
ml) and 100 ml of standard or conditioned media sample were
added per well. Plates were incubated overnight at 48C and then
washed four times as above; before addition of anti-IL-11 detection
antibody (R&D, Oxford, UK) at 100 ng/ml in ELISA buffer. Plates
were again washed four times before addition of streptavidin–peroxi-
dase (Boehringer Mannheim) at 1/2000 adding 100 ml/well for 20 min
at room temperature on a rocker. Plates were again washed four
times before addition of tetramethylbenzidine (TMB) substrate.
Colour change was monitored and stopped using 2N sulphuric acid.
Plates were read on a plate reader at 450 nM within 10 min of
quenching.
RCAN1-4 adenovirus
Adenoviral RCAN1-4 was produced using molecular cloning tech-
niques as previously published in full detail (Maldonado-Perez et al.,
2009). Brieﬂy, the cDNA of RCAN1-4 was cloned into a shuttle
vector (pDC316) and subsequently HEK 293 cells were
co-transfected with 0.5 mg pDC316-RCAN1-4 and 1.5 mg adenoviral
genomic plasmid pBHGlox E1,3 Cre. Adenoviral plaques were har-
vested 10–14 days later and virus released by 3   freeze/thaw
cycles. Clonal plaques were obtained by serial dilution and infection
of 80% conﬂuent HEK 293 cells overlaid 5 h post inoculation with
0.5% SeaPlaque Agarose (FMC Corp, Rockland, ME, USA) dissolved
in growth media. Plaques were picked 8–12 days later, inoculated
into a T75 ﬂask and incubated until 70–80% cytopathic effect (CPE)
was observed. This ﬁrst seed was inoculated into multiple ﬂasks and
harvested when CPE was apparent. RCAN1-4 adenovirus was puri-
ﬁed, concentrated, aliquoted and stored at 2808C (Vivapure Adeno-
PACK 100 puriﬁcation kit; Sartorius AG, Goettingen, Germany).
Titres were determined using the AdenoX Rapid titre kit (Clone-
Tech). Yields of in excess of 1   10
10 IFU/ml were routinely obtained.
PROKR1 Ishikawa cells were plated in 6 well plates at a density of
100 000 cells per well. After 24 h incubation, cells were washed
with PBS and 1 ml of fresh medium containing ﬁve adenovirus
pfu/plated cell was added to each well. Cells were incubated for
another 24 h and serum starved overnight before treatment with
40 nM PROK1.
Immunohistochemistry
Localization of IL-11Ra and GP130/CD56/CD68 (double) and
PROKR1, IL-11Ra and IL-11 (triple) protein expression was inves-
tigated in endometrial and decidual tissues by immunohistochem-
istry. Five-micron parafﬁn wax-embedded tissue sections were cut
and mounted onto coated slides (TESPA, Sigma). Sections were
de-waxed in xylene, rehydrated in graded ethanol and washed
in water. Antigen retrieval was performed by pressure cooking
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sequently blocked for endogenous endoperoxidase (3% H2O2 in
methanol).
For the IL-11Ra-GP130 double immunohistochemistry sections
were blocked in normal donkey serum (NDS, one part serum, four
parts PBS plus 5% BSA) and subsequently incubated overnight with
a polyclonal anti-GP130 antibody at 1:40 (Santa Cruz Biotechnology,
Wiltshire, UK). Sections were washed and stained directly with a
donkey anti-rabbit 488 ﬂuorochrome (1:200 in NDS). Sections were
washed, re-blocked in NDS and incubated overnight with a goat
anti-IL-11Ra antibody at 1:20 (A-13; Santa Cruz) followed by a
donkey anti goat 546 ﬂuorochrome (1:200 in PBS).
For the IL-11Ra-CD56/CD68 double immunohistochemistry sec-
tions were blocked in normal goat serum (NGS, one part serum,
four parts PBS plus 5% BSA) and subsequently incubated overnight
with a polyclonal anti-IL11Ra antibody at 1:700 (C-20; Santa Cruz).
Sections were washed, incubated in goat anti-rabbit peroxidase
(1:500 in NGS for 30 min) followed by ﬂuorochromes TSA-plus
cyanide 3 (1:50 in diluent for 10 min, PerkinElmer, AppliedBiosystems,
Warrington, UK). Sections were washed and blocking in NGS was
repeated before being incubated overnight with either a monoclonal
anti-CD56 (1/1500 Dako, Denmark) or a monoclonal anti-CD68
(1/800 ZYMED, California, USA) antibody. Sections were washed,
incubated in goat anti-rabbit peroxidase (1:500 in NGS) followed by
ﬂuorochromes TSA-plus cyanide 5 (1:50 in diluent).
For the triple immunohistochemistry sections were blocked in NGS
and incubated overnight with a polyclonal anti-IL-11Ra antibody at
1:700 (C-20; Santa Cruz). Sections were washed, incubated in goat
anti-rabbit peroxidase (1:500 in NGS for 30 min) followed by ﬂuoro-
chromes TSA-plus cyanide 3 (1:50 in diluent). Sections were washed,
antigen retrieval in citrate buffer and blocking in NGS was repeated
before being incubated overnight with a polyclonal anti-PROKR1 anti-
body at 1:250 (Lifespan Biosciences, Atlanta, GA, USA). Sections were
washed, incubated in goat anti-rabbit peroxidase (1:500 in NGS) fol-
lowed by ﬂuorochromes TSA-plus cyanide 5 (1:50 in diluent). Finally
after further antigen retrieval and blocking steps, sections were incu-
bated overnight with a monoclonal anti-IL-11 antibody at 1:100
(R&D Systems). Sections were washed, incubated in goat anti-mouse
peroxidase (1:500 in NGS) followed by ﬂuorochromes TSA-plus ﬂour-
escein (green) (1:50 in diluent).
All sections were washed, mounted in Permaﬂuor and visualized
using a laser-scanning microscope (meta confocal; Carl Zeiss, Jana,
Germany).
160 Cook et al.Statistical analysis
Data are represented as mean+SEM and were analysed by t test or
ANOVA using Prism 5.0c (Graph Pad, San Diego, CA, USA).
Results
PROK1 induces the expression and secretion
of IL-11 via a calcineurin–NFAT dependent
pathway in Ishikawa endometrial epithelial
cells
In order to investigate the molecular mechanisms whereby PROK1
mediates the induction of IL-11, we made use of a human endometrial
epithelial cell line, Ishikawa cells, stably expressing PROKR1 (Evans
et al., 2008). Wild-type Ishikawa and PROKR1 Ishikawa cells were
treated with vehicle or 40 nM PROK1, for the times indicated in the
ﬁgure legends. PROK1–PROKR1 stimulation in PROKR1 Ishikawa
cells resulted in a signiﬁcant increase in IL-11 mRNA expression
which was maximal between 8 and 12 h (P , 0.005, Fig. 1A). No
increase in IL-11 expression was observed in wild-type Ishikawa
cells. All subsequent experiments were conducted in the PROKR1
Ishikawa cells. Secreted IL-11 protein, as measured by ELISA was
maximal by 24 h (P , 0.005, Fig. 1B) after treatment with 40 nM
PROK1. To investigate the signalling pathways mediating the role of
PROK1 on IL-11 expression, PROKR1 Ishikawa cells were stimulated
with vehicle or 40 nM PROK1 for 6 h in the presence or absence of
the chemical inhibitors of Gq/11 (YM254890), a calcium chelator
(EGTA), ERK (PD98059), NFAT (INCA-6) or calcineurin (CSA;
cyclosporine A). Co-treatment of PROK1 cells with YM254890
(P , 0.005), EGTA (P , 0.005), PD98059 (P , 0.05), CSA (P ,
0.05) and INCA-6 (P , 0.005) inhibited the expression of IL-11
mRNA (Fig. 1C). These data indicate that IL-11 expression in Ishikawa
cells is regulated via PROK1-PROKR1 and downstream activation of
the Gq–calcium–ERK–calcineurin–NFAT signal transduction
pathway.
The IL-11 promoter region contains two
putative NFAT binding sites
As IL-11 expression is regulated via the calcineurin–NFAT signal
transduction pathway, we investigated if the IL-11 promoter sequence
contained any NFAT binding sites. Using a stringent search engine
(http://www.genomatix.de/) mapping the 50 ﬂank region we
identiﬁed two correctly orientated putative NFAT binding sites at
1.642 and 5.138 kb from the start codon for IL-11 (Fig. 1D).
PROK1 does not alter the expression of
IL-11Ra or GP130 in human endometrial
Ishikawa cells
Since we have shown that PROK1 increases the expression and
secretion of IL-11 we subsequently investigated whether PROK1
altered the expression levels of the receptors for IL-11—namely
IL-11Ra and GP130. Treatment of PROKR1 Ishikawa cells with
40 nM PROK1 had no effect on expression levels of IL-11Ra or
GP130 at any of the time points investigated (Fig. 1E and 1F).
RCAN1-4 overexpression inhibits
PROK1-induced expression of IL-11
Calcineurin signalling is known to be tightly regulated by the
RCAN1-4, previously known as Down syndrome critical region gene
1 (Davies et al., 2007). We investigated the temporal expression of
RCAN1-4 in PROKR1 Ishikawa cells within the time frame of IL-11
activation. We have shown that treatment with 40 nM PROK1 maxi-
mally induces expression of RCAN1-4 mRNA by 1.5 h in a reciprocal
manner to IL-11 (Fig. 2A) indicating that it could be a negative regula-
tor of IL-11. Hence we investigated whether RCAN1-4 acts as a nega-
tive regulator for the PROK1 regulation of IL-11 expression and
secretion. PROKR1 Ishikawa cells were infected with either empty
adenovirus or adenovirus containing RCAN1-4 for 24 h prior to
stimulation with vehicle or 40 nM PROK1 for times indicated in the
ﬁgures. Overexpression of RCAN1-4 signiﬁcantly reduced the
PROKR1 mediated induction of IL-11 mRNA expression at 8 h
(Fig. 2B; P , 0.01) and protein secretion at 12 h (Fig. 2C; P , 0.05)
compared with cells infected with the control empty virus.
IL-11, IL-11Ra and GP130 expression levels in
non-pregnant endometrium and ﬁrst
trimester decidua
RT–PCR analysis showed that IL-11 mRNA expression was signiﬁ-
cantly elevated in the late secretory phase compared with the prolif-
erative phase of the menstrual cycle (Fig. 3A; P , 0.05) and was
further elevated in ﬁrst trimester decidua compared with pooled
samples (early, mid, late and secretory phases) of non-pregnant endo-
metrium (Fig. 3B; 48.8+10.2 versus 0.36+0.06 arbitrary units; P ,
0.005). This is in agreement with the immunohistochemical obser-
vations of Dimitriadis et al. (2000) who also showed an increase in
IL-11 staining during mid secretory endometrium and a further
increase in late secretory endometrium. IL-11Ra mRNA expression
did not signiﬁcantly change across the menstrual cycle in non-pregnant
endometrium (Fig. 3C) but was signiﬁcantly reduced in ﬁrst trimester
decidua compared with pooled samples of non-pregnant endome-
trium (Fig. 3D; 1.50+0.11 versus 0.13+0.03 arbitrary units; P ,
0.001). This was in agreement with the published data by Karpovich
et al. (2003). GP130 mRNA expression was signiﬁcantly elevated in
the mid-late secretory phase compared with the proliferative phase
of the menstrual cycle (Fig. 3E; P , 0.005; P , 0.05 respectively)
but showed no signiﬁcant change between ﬁrst trimester decidua
and pooled samples of non-pregnant endometrium (Fig. 3F). This
was in agreement with the immunohistochemical observations of
Classen-Linke et al. (2004) who also showed an increase in GP130
staining during early-mid and late secretory endometrium.
Immunohistochemical expression of IL-11Ra,
GP130, IL-11 and PROKR1
Localization of the site of expression of IL-11Ra, GP130, IL-11 and
PROKR1 protein in endometrial tissue and ﬁrst trimester decidua was
investigated. Firstly, we have shown that IL-11Ra (green channel) and
GP130 (red channel) expression co-localize (yellow channel) to the
glandular epithelium and stromal compartments in mid secretory endo-
metrium and ﬁrst trimester decidua (Fig. 4A and B). Subsequently, we
investigated the co-localization of IL-11 (green channel), IL-11Ra (red
PROK1 modulates IL-11 expression via PROKR1 161channel) and PROKR1 (blue channel). In late secretory phase endome-
trium and ﬁrst trimester decidua IL-11, IL-11Ra and PROKR1 localize
to the glandular epithelium and stromal cells as indicated by the purple
channel (Fig. 4C and D). Immune cells make up a signiﬁcant component
ofdecidualtissuehenceweinvestigatedifIL-11Raco-localizedwithboth
uNK cells and macrophages. However, we found no co-localization
between IL-11Ra (red channel) and uNK cells (CD56—green channel,
Fig.4E)ormacrophages(CD68—greenchannel,Fig.4F)inﬁrsttrimester
decidua.
PROK1 induces the expression and secretion
of IL-11 but not PROKR1 or GP130 in ﬁrst
trimester decidua via a Gq–Ca
21–ERK
dependent pathway
We subsequently investigatedwhether PROK1can regulate expression
ofIL-11inﬁrsttrimesterdeciduatissueexplants.Treatmentwith40 nM
PROK1 resulted in an increase in IL-11 mRNA from 2–8 h (2.8+
0.66-fold increase; P , 0.05) to 12–24 h (3.5+0.64-fold increase;
Figure 1 Prokineticin (PROK1) induces the expression and secretion of interleukin (IL)-11, but not interleukin receptor (IL-11Ra) or glycoprotein
receptor (GP130), via a calcineurin/nuclear factor of activated T cells (NFAT) signalling pathway in PROKR1 Ishikawa cells. (A) PROKR1 Ishikawa
cells, but not wild-type cells, treated with 40 nM PROK1 for 0–24 h showed a signiﬁcant fold increase in the expression of IL-11 mRNA. (B)
PROKR1 Ishikawa cells treated with 40 nM PROK1 for 0–48 h showed a signiﬁcant increase in secretion of IL-11 protein compared with untreated
cells. (C) The induction of IL-11 mRNA by PROK1 at 6 h could be inhibited by the use of a Gq/11 inhibitor (YM254890, 1 mM), a calcium chelator
(EGTA, 1.5 mM), an ERK inhibitor (PD98059 50 mM) a calcineurin inhibitor (CSA 1 mM) and a NFAT/calcineurin inhibitor (INCA-6, 40 nM). (D)
Using a stringent search engine mapping the 50 ﬂank region two correctly orientated NFAT binding sites at 1.642 and 5.138 kb from the start codon
for IL-11 were identiﬁed http://www.genomatix.de/. (E and F) PROKR1 Ishikawa cells treated with 40 nM PROK1 for 0–24 h showed no signiﬁcant
fold change in the expression of IL-11Ra or GP130 mRNA. Data represent the mean+SEM of n ¼ 4–6 experiments. *P , 0.05 and ***P , 0.005.
162 Cook et al.P , 0.01) (Fig. 5A). PROK1 induced expression of IL-11 mRNA at 24 h
wassigniﬁcantlyreducedbyco-treatmentoftissueexplantswithaGq/11
inhibitor (P , 0.05), a calcium chelator (P , 0.01) or an ERK inhibitor
(P , 0.01) (Fig. 5B). Treatment of ﬁrst trimester decidua with 40 nM
PROK1 had no effect on expression levels of IL-11Ra or GP130
(Fig. 5C and D). We conﬁrmed that PROK1 regulates expression of
IL-11 in ﬁrst trimester decidua using a targeted PROK1 miRNA lenti-
virus.FirsttrimesterdeciduawasinfectedwithoneofthreemiRNAcon-
structs targeting PROK1 (pLenti6/V5-EmGFP-hum-PROK1-72, -287
and a chained version-72_287) and a negative scrambled control lenti-
virus (as described in Evans et al., 2009). Infection of ﬁrst trimester
decidua with either the pLenti6/V5-EmGFP-hum-PROK1-72 and -287
or the combination of 72 and 287 (-72_287) signiﬁcantly reduced
levels of both IL-11 mRNA and secreted IL-11 when compared with
the negative scrambled control construct (Fig. 5E and F).
Discussion
PROK1, but not PROKR1, has previously been shown to be regulated
across the menstrual cycle with increased expression in the mid
secretory phase (Battersby et al., 2004). Furthermore, we have
recently shown that both PROK1 and PROKR1 expression levels
are signiﬁcantly higher in ﬁrst trimester decidua compared with non-
pregnant endometrium (Evans et al., 2008). Using epithelial cells
stably expressing PROKR1 we have shown that PROK1 regulates
genes known to have important roles within the endometrium
during implantation and early pregnancy. These included LIF,
COX-2, IL-6, IL-8 and IL-11 (Evans et al., 2008). This highlighted
the potential importance of PROK1–PROKR1 signalling within the
endometrium and we focused this study on IL-11 due to its known
importance in endometrial physiology.
IL-11 is crucial for controlling decidualization and implantation—
both maternally and within the implanting embryo (Dimitriadis et al.,
2007; Guzeloglu-Kayisli et al., 2009). IL-11 is thought to mediate
these effects by controlling both cellular proliferation and differen-
tiation (Mehler et al., 1993; Du and Williams, 1994; Girasole et al.,
1994). This concurs with the observation that the IL-11Ra 2/2
female mice are infertile due to poor decidualization and (or) poor cel-
lular differentiation (Bilinski et al., 1998; Robb et al., 1998). IL-11 has
been shown to be produced and subsequently promote
Figure 2 Regulator of calcineurin 1 isoform 4 (RCAN1-4) negatively regulates prokineticin (PROK1) induced expression of interleukin (IL)-11. (A)
PROKR1 Ishikawa cells treated with 40 nM PROK1 for 0–24 h showed a signiﬁcant fold increase in the expression of RCAN1-4 and IL-11 mRNA with
maximal levels for RCAN1-4 observed at 1.5 h and for IL-11 at 8 and 12 h. (B and C) PROKR1 Ishikawa cells were infected with either empty ade-
novirus or RCAN1-4 adenovirus for 24 h. Cells were then treated with vehicle (UT) or 40 nM PROK1 (T) for 8 or 12 h. RCAN1-4 adenovirus com-
pared with the empty vector adenovirus signiﬁcantly reduced the PROK1 induced mRNA expression of IL-11 at 8 h (B) and protein secretion at 12 h
(C). Data represent the mean+SEM of n ¼ 4 experiments. *P , 0.05 and **P , 0.01.
PROK1 modulates IL-11 expression via PROKR1 163progesterone-induced decidualization in human endometrial stromal
cells (Dimitriadis et al., 2002). Furthermore relaxin and PGE2 have
both been shown to increase IL-11 levels in decidualized endometrial
stromal cells (Dimitriadis et al., 2005a, b). These reports highlight the
potential for both paracrine and autocrine actions within human
endometrial stromal cells in preparing the human endometrium for
implantation. Furthermore, in vitro studies have shown that IL-11 pro-
motes migration of human trophoblast cells, a process essential for
placentation (Paiva et al., 2007). In human decidua, IL-11 has been
shown to increase the expression of the metalloproteinase inhibitor
Figure 3 Interleukin (IL)-11, interleukin receptor (IL-11Ra) and glycoprotein receptor (GP130) mRNA expression levels in non-pregnant endome-
trium and ﬁrst trimester decidua. (A and B) Temporal expression of IL-11 mRNA across the menstrual cycle showed a signiﬁcant increase in the late
secretory phase compared with the proliferative phase of the menstrual cycle. Temporal expression of IL-11 mRNA in ﬁrst trimester decidua (n ¼ 25)
is signiﬁcantly higher than in non-pregnant endometrium [grouped samples from all stages of the menstrual cycle (n ¼ 44)]. (C and D) Temporal
expression of IL-11Ra mRNA across the menstrual cycle showed no signiﬁcant change. Temporal expression of IL-11Ra mRNA in ﬁrst trimester
decidua (n ¼ 25) is signiﬁcantly lower than in non-pregnant endometrium [grouped samples from all stages of the menstrual cycle (n ¼ 44)].
(E and F) Temporal expression of GP130 mRNA across the menstrual cycle showed a signiﬁcant increase in the mid-late secretory phase compared
with the proliferative phase of the menstrual cycle. Temporal expression of GP130 mRNA in ﬁrst trimester decidua (n ¼ 25) is not signiﬁcantly differ-
ent when compared with non-pregnant endometrium [grouped samples from all stages of the menstrual cycle (n ¼ 44)]. Proliferative n ¼ 15, early
secretory n ¼ 9, mid secretory n ¼ 10 and late secretory n ¼ 5. Data represent the mean+SEM. *P , 0.05, ***P , 0.005.
164 Cook et al.Figure 4 Immunohistochemical localization of Interleukin receptor (IL-11Ra), glycoprotein receptor (GP130), interleukin (IL-11) and prokineticin
receptor (PROKR1) in non-pregnant endometrium and ﬁrst trimester decidua. (A and B) IL-11Ra (green channel) and GP130 (red channel)
co-localize (yellow) to glandular epithelium and stromal cells in mid secretory endometrium and ﬁrst trimester decidua (n ¼ 4; representative sections
shown). (C and D) IL-11 (green channel), IL-11Ra (red channel) and PROKR1 (blue channel) co-localize (purple channel) to glandular epithelium and
stromal cells in late secretory endometrium and ﬁrst trimester decidua (n ¼ 3; representative sections shown, inset, negative control incubated with
control IgG). (E) IL-11Ra (red channel) and CD56 (green channel) and (F) IL-11Ra and CD68 (green channel) do not co-localize in ﬁrst trimester
decidua (n ¼ 4; representative sections shown).
PROK1 modulates IL-11 expression via PROKR1 165a2-macroglobulin in order to control normal placentation (Bao et al.,
2006). However, the molecular mechanism regulating IL-11 and its
autocrine/paracrine role in human uterine function of early pregnancy
is unclear.
In the present study, we report that PROK1 induces the expression
and secretion of the cytokine IL-11 in cultured endometrial epithelial
cells and ﬁrst trimester decidua explants. Furthermore we have
shown that the PROK1–PROKR1 induction of IL-11 is mediated via
the calcineurin signalling pathway in a Gq/11, calcium and ERK depen-
dent manner as shown schematically in Fig. 6. Calcium dependent acti-
vation of calcineurin results in dephosphorylation of cytoplasmic
NFAT, leading to NFAT translocation to the nucleus enabling it to
activate NFAT regulated gene transcription. Using a highly stringent
search we have identiﬁed two correctly orientated putative NFAT
binding sites within the IL-11 promoter. Moreover, using a speciﬁc
inhibitor, INCA-6, which is known to block the interaction between
calcineurin and NFAT (Roehrl et al., 2004), we have shown that inhi-
biting NFAT signalling can block PROK1-PROKR1 mediated
expression of IL-11.
RCAN1-4 is an endogenous modulator of the calcineurin signalling
pathway. Previous studies in our laboratory have identiﬁed that
PROK1 can induce expression of RCAN1 by gene array analysis
(Evans et al., 2008). RCAN1-4 is known to bind to calcineurin and
previous studies have shown that overexpression of RCAN1-4
Figure 5 Prokineticin (PROK1) induces the expression and secretion of interleukin (IL-11) but not interleukin receptor (IL-11Ra) or glycoprotein
receptor (GP130) in ﬁrst trimester decidua. (A) First trimester decidua explants treated with 40 nM PROK1 for 0–24 h showed a signiﬁcant fold
increase in the expression of IL-11 mRNA. (B) The induction of IL-11 mRNA by PROK1 treatment for 24 h could be signiﬁcantly inhibited by the
use of a guanine nucleotide-binding protein (Gq/11) inhibitor (YM254890, 1 mM), a calcium chelator (BAPTA-AM, 50 mM) and an ERK inhibitor
(PD98059, 50 mM). (C and D) First trimester decidua explants treated with 40 nM PROK1 showed no signiﬁcant fold change in the expression of
IL-11Ra or GP130 mRNA. First trimester decidua were infected with miRNA constructs targeting PROK1 (72, 287 and 72_287) or a scrambled
control sequence for 72 h. IL-11 mRNA expression (E) and protein secretion (F) were both signiﬁcantly reduced by all miRNAs targeted to
PROK1 compared with the scrambled control. Data represent the mean+SEM of n ¼ 3–8 experiments. *P , 0.05, **P , 0.01 and ***P , 0.005.
166 Cook et al.results in an inhibition of calcineurin activation of NFAT (Minami et al.,
2004; Chan et al., 2005). Here, we have shown that RCAN1-4 is tem-
porally regulated in a reciprocal manner to expression of IL-11 by
PROK1–PROKR1. Moreover we have shown that overexpression of
RCAN1-4 leads to a reduction in PROK1 induced IL-11 indicating
that RCAN1-4 is acting as a negative regulator of PROK1–PROKR1
mediated IL-11 signalling as summarized in Fig. 6.
In order to conﬁrm the physiological relevance of our data, we
investigated the effect of PROK1 on expression of IL-11 in ﬁrst trime-
ster decidua tissue explants. In accordance with our observation using
the PROKR1 Ishikawa cell line, we showed that IL-11 in ﬁrst trimester
decidua is also regulated by PROK1, since treatment of decidua tissue
with exogenous PROK1 increased IL-11 induction. We further con-
ﬁrmed PROK1 regulation of IL-11 in ﬁrst trimester decidua using
miRNA constructs targeted to PROK1. Ablation of endogenous
PROK1 in ﬁrst trimester decidua inhibited IL-11 expression conﬁrming
that PROK1 regulates the basal expression and secretion of IL-11.
IL-11 is a secreted cytokine which is known to signal via its recep-
tors, IL-11Ra and GP130; hence we investigated the potential for
autocrine or paracrine signalling by localizing the sites of protein
expression of GP130, IL-11Ra, IL-11 and PROKR1. Immunohisto-
chemistry showed that both IL-11Ra and GP130 co-localized in gland-
ular epithelium and stromal compartments of both endometrium and
ﬁrst trimester decidua. This was in agreement with the published data
by Karpovich et al. (2003) and Classen-Linke et al. (2004). We have
also shown co-localization of IL-11, IL-11Ra and PROKR1 in glandular
epithelium and stroma suggesting the potential for PROK1–PROKR1
to regulate IL-11 expression in both compartments during endometrial
receptivity and early pregnancy in an autocrine–paracrine manner.
Immune cells make up a signiﬁcant component of decidual tissue
and IL-11 has been shown to be important in the differentiation of
uNK cells in decidua (Ain et al., 2004). However, we saw no
co-localization between IL-11Ra and uNK cells or macrophages in
decidua. This suggests that the role of IL-11 in regulating uNK cell
differentiation is by an indirect non-paracrine mechanism.
Subsequently, we have shown that both IL-11 and GP130 mRNA
expression are elevated in the late secretory phase of the menstrual
cycle whereas IL-11Ra shows no change. IL-11 is further elevated in
ﬁrst trimester decidua but conversely IL-11Ra is signiﬁcantly lower
compared with non-pregnant endometrium. This is likely to be a com-
pensatory mechanism accounting for the large increase in IL-11, as
seen in ﬁrst trimester decidua and acts to control IL-11’s signalling
potential and to maintain speciﬁcity between other GP130 signalling
cytokines. GP130 showed no difference between non-pregnant endo-
metrium and ﬁrst trimester decidua which is in agreement with
Classen-Linke et al. (2004).
Taken together, our data suggest that PROK1–PROKR1 signalling
to IL-11 could play a vital role in decidualization, implantation and
maintenance of pregnancy. IL-11 is known to enhance progesterone
mediated decidualization and that relaxin and PGE2 enhance IL-11
expression (Dimitriadis et al., 2002, 2005a, b). Therefore PROK1–
PROKR1 could increase IL-11 expression and secretion directly
during decidualization in a complementary manner. IL-11 induction
via PROK1–PROKR1 may affect blastocyst implantation by increasing
the expression of the metalloproteinase inhibitor, a2-macroglobulin,
or via IL-11 mediated migration of trophoblast cells (Bao et al.,
2006, Paiva et al., 2007). Recently, it has been shown that IL-11 can
increase the adhesion of human endometrial epithelial cells to both
ﬁbronectin and collagen IV and that IL-11 could increase adhesion
of trophoblast cells to endometrial cells (Marwood et al., 2009)
again suggesting IL-11 could be regulating the process of implantation.
In conclusion, our data has mapped out for the ﬁrst time, the intri-
cate molecular mechanisms whereby IL-11 is regulated in endometrial
epithelial cells and ﬁrst trimester decidua by PROK1. Our ﬁndings
together with others suggest that PROK1 may be important in regulat-
ing decidualization and human fertility via the expression of IL-11. Dys-
regulated expression and/or signalling of the prokineticin pathway may
contribute to female infertility.
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Figure 6 Schematic representation of Prokineticin (PROK1) induc-
tion of regulator of calcineurin 1 isoform 4 (RCAN1-4) and interleukin
(IL-11). Activation of the PROKR1 by PROK1 results in the induction
of IL-11 expression. This occurs via coupling to Gq/11 protein. This
results in an intracellular increase in calcium which activates calci-
neurin and subsequently dephosphorylates cytoplasmic NFAT. This
allows NFAT to migrate to the nucleus and bind to NFAT binding
motifs in the promoter of IL-11 and induce its transcription.
PROK1 also up-regulates RCAN1-4 expression which acts as a nega-
tive regulator and reduces the level of IL-11 transcription by binding
to calcineurin and hence inhibiting NFAT dephosphorylation.
Gq¼ Gq protein alpha subunit, Ca
2þ ¼ intracellular ionized calcium,
ERK ¼ extracellular signal-regulated kinase, Cam ¼ calmodulin,
CnA ¼ calcineurin catalytic subunit, CnB ¼ calcineurin regulatory
subunit and NFAT ¼ nuclear factor of activated T-cells.
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